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Substantial progress has been made in recent years to augment the current understanding of structures and interactions that promote viral
membrane fusion. This progress is reviewed with a particular emphasis on recently determined structures of viral fusion domains and their
interactions with lipid membranes. The results from the different structural and thermodynamic experimental approaches are synthesized into
a new proposed mechanism, termed the ‘‘spring-loaded boomerang’’ mechanism of membrane fusion, which is presented here as a
hypothesis.D 2003 Elsevier B.V. All rights reserved.Keywords: Membrane fusion; Fusion peptide; Hemagglutinin; Structure; Folding; Energetic; Lipid–protein interaction1. Introduction
Enveloped viruses enter cells by membrane fusion.
Thanks to evolution, viruses accomplish this task by the
use of specialized envelope glycoproteins, i.e. fusion pro-
teins, that cooperate to form a sophisticated molecular
machine to merge viral and cellular target membranes
without loosing contents to the environment. Much insight
into how these molecular machines work has been gleaned
from X-ray crystallographic studies of the soluble ectodo-
mains of several viral fusion proteins [1]. The common
theme that has emerged from these structural studies is that
class I1 fusion proteins consist of three identical subunits that
fold into long trimeric coiled coils of a-helices along the
threefold symmetry axis of the core structure. These core
coiled coils are surrounded by a second layer of three shorter
a-helices that are oriented antiparallel to the central helices.0005-2736/03/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/S0005-2736(03)00159-7
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1 Class II fusion proteins such as those found in flavi- and alphaviruses
have a different architecture. They consist of mostly h-structured dimers
that lie flat on the viral membrane where they assemble into an icosahedral
scaffold [45–47]. Class II fusion proteins have small polypeptide loops at
one end that are thought to serve as fusion peptides. The mechanism of
fusion of class II fusion proteins is much less well understood than that of
class I fusion proteins and is not reviewed here.The hemagglutinin (HA) of influenza virus has long
served as the paradigm viral fusion protein. Influenza HA
gained this prominent role because its structure was solved
in pioneering work more than 20 years ago [2]. Each subunit
of the HA trimer contains two poypeptide chains, HA1 and
HA2. The HA1 chains harbor the receptor binding sites for
virus attachment to the cell surface. The HA2 chains are
thought to be primarily responsible for the fusion activity.
Unlike some other viruses that fuse at neutral pH directly
with the cell membrane, influenza virus first enters cells as
an intact particle by receptor-mediated endocytosis. Fusion
is then triggered by the mildly acidic pH (around 5) that
prevails in the endosome. Remarkably, the structure of HA
refolds completely in response to this pH change [3].
Although it is known that the trimer contacts between
HA1 subunits are loosened upon activation by pH 5 [4,5],
the low-pH structures of these subunits are not known (but
see Ref. [6] for a structure of the HA1 monomer at pH 6).
The bundles of coiled coils discussed above are part of the
HA2 polypeptide chains. In the crystallographically ob-
served refolding reaction [3], only the top (N-terminal)
halves of the central coiled coils remain intact. The bottom
(C-terminal) halves break off, form a tight 180j turn, and
pack antiparallel against the core helices. In contrast, the
original antiparallel outer helices, which at neutral pH are
connected by long extended loops to the top ends of the
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extend the original core helices at their N-terminal ends to
form long new continuous helices at the top. This major
refolding reaction redirects the free N and C termini of the
soluble portion of the HA2 chain from the bottom (C-
terminal) to the top (N-terminal) end of the long triple
coiled coil where they form a hydrogen-bonded threefold
symmetric cap structure [7].
The energetics of the refolding of the HA2 core particle
has been determined [8–10]. From these studies it became
clear that the pH 5 core structure is at a lower energy than the
pH 7 structure and that the refolding reaction is essentially
irreversible. The pH 7 structure is a kinetically trapped
metastable structure that can release stored energy only upon
lowering the activation energy that is associated with the
structural transition. The activation energy can be lowered by
exposing the molecule to pH 5 or high temperatures. It is a
common assumption that the energy that is stored in the pH 7
structure contributes to the force that drives membrane
fusion. This part of the fusion mechanism has been termed
‘‘spring-loaded’’ [8] because release of the proteinaceous
clamp that holds the pH 7 structure in the metastable state
leads to the complete inversion of the helices and thus the re-
orientation of N- and C-terminal ends of HA2.
What happens in solution in between the two membranes
that are to be fused is obviously only one aspect of the
mechanism that leads to membrane fusion. Another impor-
tant aspect deals with the structures and interactions with
lipid bilayers of the hydrophobic domains of HA, namely
the so-called ‘‘fusion peptide’’ at the N-terminal end and the
transmembrane (TM) domain at the C-terminal end of the
HA2 polypeptide chain. In order to obtain suitable crystals,
these hydrophobic domains have been removed from the
core structure that was crystallized at pH 5. The crystallo-
graphically determined structure of HA2 at pH 5 comprises
residues 34 to 185 [7]. However, the fusion peptide extends
from residue 1 to residues 20–24 and the TM domain
comprises residues 185–208 of HA2. While the TM
domains constitutively anchor HA in the viral membrane,
the fusion peptides are shielded in hydrophobic crevices
between the HA subunits in the pH 7 structure. They
become exposed to membranes only after the low-pH-
induced conformational change [11,12]. In this review, I
summarize what is known about the structures of HA fusion
peptides and TM domains in membranes and then proceed
to energetic considerations of fusion peptide–membrane
interactions. I will briefly review some biochemical and
biophysical evidence for possible roles of the ectodomains
in membrane interactions and will finally propose a new
model for fusion that is based on these collective results.2. Structures of fusion peptides in membranes
The ‘‘fusion peptide’’ refers to a moderately hydrophobic
sequence of approximately 20 residues that is present in allviral fusion proteins and that is capable of inserting into the
lipid bilayer of the target membrane when the fusion protein
is activated. These sequences are usually highly conserved
among different strains of the same virus. Even very
conservative single point mutations have been shown to
ablate fusion of many viral fusion proteins. Fusion peptides
are generally rich in glycines and, in some cases, alanines.
These residues endow the fusion peptides with an unusual
conformational flexibility as will be discussed in more detail
further below. This flexibility is a hallmark of fusion
peptides and may very well be important for their function.
The fact that fusion peptides may exist in different con-
formations is probably also the reason for many conflicting
results that can be found in the relevant literature. Environ-
ment and exact experimental conditions can markedly affect
the observed structures and, therefore, care should be taken
when results from different laboratories are compared.
As is true for the majority of, but not all, viral fusion
peptides, the fusion peptide of influenza HA is located at the
extreme N terminus of the fusion-promoting subunit, i.e. the
HA2 chain in the case of the influenza fusion protein. The
influenza fusion peptide comprises 20–24 residues as
defined by the apolar/polar residue boundary. The fusion
peptide is then followed by nine polar residues, which,
although present in the protein that was crystallized at pH 5,
do not adopt any ordered structure in these crystals [7].
Therefore, the fusion peptide likely constitutes an indepen-
dently folded domain of the fusion protein when it inserts
into the membrane. The structure of this domain is stabilized
and defined by interactions with the lipid bilayer. Therefore,
the fusion peptide is sometimes also called the ‘‘fusion
domain’’ of the fusion protein.
Early circular dichroism (CD) experiments of synthetic
peptides comprising the first 20 residues of HA2 indicated
that the influenza fusion peptide is about 50% helical in
lipid bilayers or other apolar environments [13–15]. Gray et
al. [16] showed that a 23-residue HA fusion peptide adopts a
small amount (20–30%) of h-structure in addition to the
predominantly a-helical structure. The relative contents of
a- and h-structures are strongly dependent on even small
details of the sequence, with some sequences that do not
promote fusion in the context of the full-length proteins
showing much higher contents of h-structures. Polarized
Fourier transform infrared (FTIR) spectra showed that the
helical segments of the 23-residue peptide are, on average,
oriented approximately 50j from the membrane plane [16].
Ishiguro et al. [17] prepared a more soluble 20-residue
analog of the influenza fusion peptide, called E5, in which
glycines 4 and 8 and threonine 15 were replaced by
glutamate residues. This peptide is also predominantly
helical, promotes lipid mixing in a pH-dependent manner
as the wild-type sequence, and has its a-helical components
oriented f 20j from the membrane plane. Lu¨neberg et al.
[18] report an average angle of f 45j from the membrane
plane for the helical components of the 20-residue wild-type
peptide sequence. Apart from differences in peptide se-
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different in these studies. Since the native peptide sequences
are not or only sparingly soluble in water, they are usually
combined with lipids in organic solvent and the complexes
are rehydrated after solvent removal. Especially for con-
formationally flexible peptides, this procedure does not
always lead to equilibrium structures in membranes as has
been amply demonstrated for another hydrophobic peptide,
i.e. gramicidin A [19]. In addition, some investigators
prepare multilayers of only partially hydrated films of lipid
to record polarized FTIR spectra. The absence of bulk water
in these membrane preparations may adversely affect the
secondary structures and orientations of amphipathic fusion
peptides that reside at the membrane/water interface.
To eliminate these potential sources of error, we have
recently developed ‘‘second-generation’’ fusion peptides,
which are linked at their C terminus to a polar carrier
peptide via a flexible linker [20]. Because the fusion peptide
is most likely an independent folding domain in membranes
and because the linker to the peptide is designed to be
flexible, we believe that the presence of the carrier peptide
does not (significantly) affect the structure and membrane
interactions of the fusion peptide proper. This general design
was highly successful to determine high-resolution struc-
tures of various analogs of the influenza fusion peptide in
detergent micelles and lipid bilayers. The sequence of the
20-residue wild-type fusion peptide (P20) and the linked
polar carrier or host peptide (H7) is
P20H7: GLFGAIAGFIENGWEGMIDG
 GCGKKKK  CONH2
An initial characterization of this peptide, which is
soluble in water at quite high concentrations, by CD and
FTIR spectroscopy shows that it is f 90% random coil in
solution and f 48% ( = 13 residues of P20, H7 is unstruc-
tured) helical in lipid bilayers [20]. P20H7 and other host-
guest fusion peptides bind to model membranes from
aqueous solution, i.e. they can be delivered to membranes
as they presumably would be in vivo. The average orienta-
tion of the helical segments is f 33j from the membrane
plane as determined by polarized FTIR spectroscopy of
fully hydrated single supported bilayers [20]. Not only is
this average angle smaller than what has been measured
before with the same methods for the fusion peptide without
the linked host peptide, but the standard error of the
measurement is also much smaller with the solubilized
peptide. The peptides delivered from solution probably find
a narrower energy minimum and likely reach equilibrium,
whereas multiple conformations may be present and kinet-
ically trapped when the peptides are delivered from organic
solvents.
With the new peptide design, their atomic structure in
detergent micelles in solution could be determined by NMR
spectroscopy [21]. In these experiments, P20H7 was boundto perdeuterated dodecylphosphocholine (DPC) micelles at
a ratio of 1:100. The structures were then solved by 1H-
NMR at pH 7 and pH 5 as shown in Fig. 1. Both structures
are characterized by a well-defined N-terminal a-helix that
extends from residue 2 to residue 10. Residues 11, 12, and
13 form a turn and redirect the polypeptide chain by about
60j so that it forms a ‘‘V’’ with an opening angle of about
120j. The C-terminal arm does not form a regular secondary
structure at pH 7, but forms a short 310-helix comprising
residues 14–18 at pH 5. The N-terminal helix is amphi-
pathic with all bulky hydrophobic residues on the inner side
and a ridge of conserved glycines on the outer side of the
angled structure. The open C-terminal arm of the pH 7
structure is not clearly amphipathic. Polar and apolar resi-
dues project to the inside and outside. However, folding of
the C-terminal 310-helix induces an amphipathic structure in
this arm as well: Glu 15 and Asp 19 move from the inside to
the outside and Met 17 moves to the inside of the ‘‘V’’.
Folding of the C-terminal 310-helix therefore creates a
completely hydrophobic pocket filled with many bulky
aromatic residues in the cavity of the ‘‘V’’.
Two NMR structures of the ‘‘E5’’ peptide, which con-
tains five glutamates (see above), are also available [22,23].
Although the details are different, some general aspects of
these two structures are similar to those of the native fusion
peptide. Both structures, one in DPC and the other in SDS
micelles, consist of two well-ordered helical segments
connected by a hinge that extends roughly from Glu 11 to
Trp 14 at pH 4–5. Dubovskii et al. [22] report that Glu 11
and Glu 15 have unusually high pKa’s of 5.6. If confirmed in
the native fusion peptide, protonation of these groups may
render the outer surface of the ‘‘V’’ less polar and may allow
a deeper insertion of the fusion domain into the bilayer (or
micelle) at pH 5 than at pH 7. The deeper insertion of the
glutamates may induce the folding of the C-terminal 310-
helix, render this segment more amphipathic, and thereby
facilitate the insertion of the entire structure deeper into the
membrane.
Detergent micelles are much more curved and much more
dynamic assemblies than lipid bilayers. It is therefore of
interest to know whether the structures that were determined
by NMR in detergent micelles are representative of the
structures of these peptides in lipid bilayers. To address this
question, we have determined the structures of P20H7 in
lipid bilayers by spin-label EPR spectroscopy at pH 7 and pH
5 [21]. All 20 residues of the fusion peptide were individ-
ually labeled with a nitroxide spin label. Spin labeling Gly 4
and Gly 8 altered the structure of the fusion peptide. Spin
labels in the other 18 positions did not appear to have a major
perturbing effect on the fusion peptide structure as judged by
CD and FTIR spectroscopy. The position of each of these 18
residues in lipid bilayers was then determined by power-
saturation EPR spectroscopy in the presence of O2, N2, and a
Ni complex [24]. The final result of these experiments is
shown in Fig. 2A. The dispositions of residues in the lipid
bilayer have striking similarities to the NMR structures in
Fig. 1. Structures of influenza hemagglutinin fusion peptide determined by NMR in DPC micelles at pH 5 (left) and pH 7.4 (right). (A) Ribbon representations.
(B) Surface potential representations of top view (top), side view (middle), and bottom view (bottom). Red represents negative and blue positive surface
potentials. The green arrow points to the hydrophobic pocket in the pH 5 structure (adapted from Ref. [21]).
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helix extending between residues 1–11, the kink, as well as
the C-terminal helix are evident in the EPR structure at pH 5.
The more extended C-terminal arm at pH 7 is also apparent.
Therefore, it is reasonable to assume that the structures in
lipid bilayers are very similar to those in detergent micelles at
pH 7 and pH 5.
In addition, the EPR structure defines the angle between
the N-terminal a-helix and the membrane plane. This angle
is 23j at pH 7 and 38j at pH 5. The 38j determined by EPR
for the N-terminal arm is in good agreement with the 33j
previously determined by polarized FTIR for the average of
the whole peptide [20]. The agreement between two com-
pletely different methods of orientation determination vali-
dates both methods as well as the optical constants that havebeen used to extract the order parameter from the measured
FTIR dichroic ratios. The EPR data further show how deep
the peptide penetrates the lipid bilayer. The EPR constraints
can be used to dock the NMR structures at the membrane
interface. The structures shown in Fig. 2B indicate that the
Ca of Asn 12, which forms the apex in both structures, is
coplanar with the average phosphorus position of the
phospholipids at both pH values. The N terminus is seen
to penetrate about 6 A˚ deeper into the bilayer at pH 5 than at
pH 7. If side chains are included the deepest residues (Leu 2
and Phe 3) reach about 16–17 A˚ (measured from the lipid
phosphate groups) into the proximal leaflet at pH 5, i.e.
almost to the mid-plane of the lipid bilayer. Of course, these
structures as well as that of the lipid bilayer should be
viewed as highly dynamic structures with quite large verti-
Fig. 2. Position of influenza hemagglutinin fusion peptide in lipid bilayers at pH 5 (red) and pH 7.4 (blue or yellow). (A) Distance measurements of residues by
power-saturation spin-label EPR spectroscopy. The same kinked structures with N-terminal a-helical arms are seen as observed by NMR in detergent micelles.
(B) High-resolution NMR structures docked to the EPR distance constraints in lipid bilayers. A phospholipid is drawn on the same scale for reference (adapted
from Ref. [21]).
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molecular dynamics calculations will likely shed some
interesting new light on the dynamics of these assemblies.
The structures of two functionally important fusion pep-
tide mutants have also been determined by NMR in detergent
micelles. The G1S mutation causes full-length HA to pro-
mote ‘‘hemifusion’’, but not full fusion [26]. ‘‘Hemifusion’’
is thought to be an intermediate state on the path to full
fusion and is operationally defined by a state in which
fluorescent lipid dyes exchange between two closely ap-
posed membranes, but fluorescent aqueous dyes do notcommunicate across a fusion pore. In full fusion, lipid and
contents markers exchange between HA expressing and
target cells. The G1V mutation blocks fusion completely
so that it does not even proceed to the hemi-fused state [26].
The NMR structure of G1S is very similar to that of the wild-
type P20H7 peptide (Fig. 3A). It still forms an angled
amphipathic structure with all bulky apolar residues seques-
tered into the hydrophobic pocket of the ‘‘V’’. Only the
glycine ridge on the outer surface of the N-terminal helical
arm is disrupted. In contrast, the NMR structure of G1V
shows a very irregular approximately linear amphipathic
Fig. 3. Structures of G1S (A) and G1V (B) mutant influenza hemagglutinin
fusion peptides determined by NMR in DPC micelles at pH 5 (X. Han and
L.K. Tamm, unpublished results).
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helix is oriented approximately parallel to the membrane
surface. Based on the structures of these two mutations, it
appears that an angled and thus deeply membrane inserted
structure is necessary, but not sufficient to promote mem-
brane fusion.Fig. 4. Free energies, enthalpies, and entropies of influenza hemagglutinin
fusion peptide binding to lipid bilayers of POPC/POPG (4:1) at 25 jC.
Entropies were converted into energy units by multiplication with  298 K.
P8H7. . .P20H7 refer to fusion peptides of increasing lengths. G1S and G1V
are position-1 point mutations of P20H7 (from Ref. [27]).3. Folding and insertion of fusion peptides in
membranes
Because P20H7 is water-soluble, the thermodynamics of
membrane binding could be studied in quite some detail. As
is true for other amphipathic peptides, membrane insertion is
coupled to folding of the fusion peptide. We studied the
binding of P20H7 and several shorter influenza fusion
peptide analogs (P8H7, P13H7, P16H7) to lipid bilayers
by a fluorescence method using NBD-labeled analogs of
these peptides [20]. Contributions that are due to the elec-
trostatic attraction of the positively charged peptides to the
negatively charged bilayers are eliminated by applying a
Boltzmann factor weighted by the electrostatic surface
potential to the measured binding constant. The electrostatic
surface potential is calculated at each peptide concentration
from the Gouy–Chapman theory of the diffuse ionic double
layer near charged surfaces. The resulting intrinsic binding/
partition constant Ko is then used to calculate the free energy
of binding
DG ¼ RT lnð55:5KoÞ:
The factor 55.5 is the molarity of water at 25 jC and
accounts for its cratic contribution to the free energy ofbinding. Finally, the contribution of the host peptide H7 is
subtracted by measuring its binding to lipid bilayers and
calculating
DDG ¼ DGðPnH7Þ  DGðH7Þ ðn ¼ 8; 13; 16; 20Þ
Fig. 4 shows that all values of DDG are negative and
decrease approximately linearly with increasing peptide
length. Not surprisingly, increasingly more free energy is
gained as the peptide gradually ‘‘grows’’ into the lipid
bilayer. Fig. 4 also shows that the negative free energy of
G1S is not much reduced, but the negative free energy of
G1V is greatly reduced compared to that of the wild-type
fusion peptide. This indicates that G1S likely inserts almost
as deep as the wild-type peptide into lipid bilayers, whereas
G1V is likely more surface-located. These results are
consistent with measurements of helix orientation obtained
by polarized FTIR spectroscopy. The G1S and wild-type
peptide orientations are oblique and very similar to each
other, but the helix of G1V is oriented parallel to the
membrane plane.
The enthalpies of binding of these peptides to lipid
bilayers have been studied by isothermal titration calorim-
etry (ITC) [27]. Values of DDH have been obtained in much
the same way as DDG, namely by subtracting the contribu-
tion of the host peptide from those of the host-guest fusion
peptides. Knowing the free energies and enthalpies of
binding, the entropies of binding can be calculated from
DDG ¼ DDH  TDDS
These values are also plotted in Fig. 4. For all peptides,
the enthalpies are more negative than the free energies.
Therefore, binding of the fusion peptides to small unila-
mellar vesicles is driven by enthalpy and opposed by
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the classical entropy-driven hydrophobic effect were the
major driving force for binding and inserting fusion pep-
tides into lipid bilayers. In contrast, binding of fusion
peptides to lipid bilayers is driven by enthalpy. It should
be noted, however, that this result may only apply to highly
curved membranes. Other peptides have been shown to bind
to SUVs with a large negative enthalpy, but to LUVs with a
positive enthalpy, although the free energies of bind-
ing were approximately the same in SUVs and LUVs
[28]. Membrane curvature may thus determine whether
binding is enthalpy- or entropy-driven. At least in SUVs,
the binding of the fusion peptides is associated with a
negative entropy change and thus the entropic contribution
to the free energies is positive for all peptides of varying
length and sequence (Fig. 4). About 50% of the enthalpy of
binding is due to folding and another 50% is due to
membrane insertion [27]. Thus, formation of the V-shaped
fusion domain structure and its deep insertion into the lipid
bilayer contribute about equally to the energetics of mem-
brane fusion.
Fusion peptides self-associate at membrane surfaces at
high concentrations [29]. This is evident from binding
isotherms that deviate in shape from the simple isotherms
that would be expected for partitioning as monomers into
lipid bilayers. The onset of this effect depends on the
specific sequence, but for the wild-type fusion peptide
P20H7 starts at about 1 peptide per 300 lipids at pH 5
and about 55 mM ionic strength [29]. FTIR spectroscopy
shows that the self-associated peptides adopt an antiparallel
h-sheet conformation. The self-association of a-helical
monomeric fusion peptides into oligomeric associated h-
sheets is reversible. Binding to lipid bilayers in both forms
is also reversible. Finally, unstructured fusion peptides
aggregate at intermediate to high ionic strength into h-
structured oligomers in solution. Taken together, these
observations of the different forms of the fusion peptide
in solution and in membranes combine to the thermody-Fig. 5. Thermodynamic cycle for the insertion, folding, and self-association
of influenza hemagglutinin fusion peptides in lipid bilayers (from Ref.
[29]).namic cycle depicted in Fig. 5. The equilibrium of the non-
fusogenic mutant G1V is strongly shifted towards the
antiparallel h-sheet form in membranes. G1S is intermedi-
ate between wild-type and G1V with regard to this equi-
librium. Therefore, it appears that the fusogenic form is the
helical form, whereas excessive self-assembly and h-sheet
formation at the membrane surface is inhibitory to fusion.
Although the helical form is likely the fusogenic form, a
controlled proportion of fusion peptides in the h-sheet form
may have a functional role at some stage in fusion, for
example by facilitating the assembly of trimers into oligo-
meric fusion sites.4. Structure of TM domains in membranes
The structure of the TM domain of influenza HA has
been studied by CD and polarized FTIR spectroscopy in
detergent micelles and lipid bilayers [30]. As expected, it is
highly helical in both environments. At least 19 residues are
helical in bilayers of the zwitterionic lipid DMPC. More a-
helix (up to 27 residues) is induced, when the peptide,
which is flanked by positively charged residues at both
ends, is reconstituted into negatively charged bilayers of
DMPG. Polarized FTIR experiments show that the peptide
is oriented perpendicular to the membrane plane. At low
peptide concentrations, the helix axis deviates not more than
15j from the membrane normal. When the peptide/lipid
molar ratio is increased to 3.7%, the orientation angle
increases to 12–26j. Polyacrylamide gel electrophoresis
experiments indicate that the HA TM peptides have a
tendency to form oligomers in SDS micelles. Dimers,
trimers, and tetramers are found. Therefore, it is possible
that in the native HA structure, which is a trimer, the TM
domains also associate to form trimers. Finally, amide
hydrogen-exchange experiments indicate that the TM
domains in lipid bilayers are quite accessible to water.
These observations are consistent with the TM domains
forming oligomers, perhaps even water-accessible pores, in
lipid bilayers. One face of the modeled TM a-helix contains
several conserved serines and cysteines, which are likely
shielded from lipid contacts and perhaps define a water-
accessible channel along the center of the oligomer.5. Roles of the ectodomains in membrane fusion
The pH-triggered ‘‘spring-loaded’’ conformational
change of the ectodomain of influenza HA [8,9] was
described in the introduction. Energy is released upon
refolding of the coiled-coil a-helices. The pH 5 conforma-
tion also places the N and C termini of the ectodomain and
thus the fusion and TM domains in close spatial proximity
to each other. How does this structure and possible inter-
mediates on the path to the final pH 5 structure fit in
between the two membranes that are to be fused? How
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fusion? Some insight into the structural role of the ectodo-
mains in membrane fusion comes from polarized FTIR
experiments of full-length HA and some of its fragments
[31–34]. The helical coiled coils of strain A/PR/8/34 HA
are tilted by a large angle at pH 5, but approximately
upright at pH 7 [31]. If the fusion peptide inserted into
the target membrane before or during tilting, the tilting
would provide a mechanism to pull the target and viral
membranes into close proximity. The height of the HA
trimer and therefore the distance between the two mem-
branes to be fused is about 13 nm at pH 7. A 70j tilt
reduces this distance to about 4 nm, i.e. to a range where
membrane–membrane interactions become effective. The
HA tilt is reversible in the absence of target membranes, but
irreversible in their presence [32]. Therefore, titling may not
be a protein-driven process, but rather a membrane-driven
process. A possible scenario is that the upright conforma-
tion at pH 7 is held in place by a protein clamp, which is
released at pH 5. The clamp may be reattached in the
absence of target membranes, but removed from interaction
with the core protein in the presence of target membranes, if
the clamp interacts with these membranes. Possible candi-
dates for the proposed clamp could be parts of the HA1
domain, which have been shown to interact with lipid
bilayer model membranes [34]. Another region of the
ectodomain that interacts with model membranes comprises
the turn residues that connect the major core helices with
the antiparallel packed helices at pH 5 [35,36]. Biochemical
evidence for reversible refolding steps in HA-mediated
fusion support these ideas [37]. The titling has been
confirmed with strain X:31 HA and extended to various
of its fragments [33]. Tilting of the coiled coils implies a
hinge at the base of HA, i.e. near the TM domain. Using
fragments lacking the TM domain, but inserting into model
membranes via the fusion peptide, a second hinge between
the fusion peptide and the ectodomain has been identified
[34]. Several studies using a variety of different approaches
have found that several HA trimers act in concert at a single
fusion site [38–41]. Fusion is therefore a cooperative
process with respect to HA. After inserting the fusion
peptides into the target membrane, several trimers tilt
presumably simultaneously towards each other, pull the
membranes to be fused into close proximity, and thereby
establish a precursor of the fusion pore.6. Spring-loaded boomerang model of viral membrane
fusion
Combining the results obtained with the ecto-, fusion,
and TM domains, we propose the following ‘‘spring-loaded
boomerang’’ model of influenza HA-mediated membrane
fusion. Although some elements of this proposal have not
yet been experimentally confirmed, the model serves as a
working hypothesis to guide the design of future experi-mentation. In this model, we envision the following se-
quence of events leading to HA-mediated membrane
fusion: (1) The pH change leads to the extrusion of the
fusion peptides from the protective hydrophobic crevices in
the pH 7 structure of the ectodomain. (2) The coiled coils of
HA2 extend towards the target membrane. (3) The fusion
peptides insert into the target membrane where they adopt
the V-shaped ‘‘boomerang’’ structure shown in Fig. 1 and
schematically depicted in Fig. 6 (panel A). Steps 2 and 3
are exothermic. Energy is gained by forming the extended
coiled coils and by inserting the fusion peptides into the
lipid bilayer of the target membrane (Fig. 4). This energy
can be expended on dehydrating and possibly bending the
membranes that are to be fused. (4) Several HA trimers
assemble to form a single fusion site. Potentially, this as-
sembly could be driven by the self-assembly of fusion pep-
tides in the membrane (Fig. 5). However, the timing of the
assembly of HA trimers in physiological membrane fusion
is not known. (5) The ectodomains tilt towards the plane of
the viral and target membranes (Fig. 6B). This lateral excur-
sion of the ectodomains is likely coupled to the induction of
the tight turns between the long coiled coils and the short
antiparallel C-terminal helices observed in the pH 5 struc-
ture. The structural change brings the fusion and TM pep-
tides in to close proximity and the titling lets the two
membranes approach each other. The net effect is a retrieval
of the boomerang to a position close to from where it was
initially released. It is not yet known whether this retrieval
is driven by membrane or protein interactions, or both.
(6) Dehydration and possibly other perturbations of the
target and viral membrane [30,42] will further decrease the
distance between the two membranes to the extent that the
lipids of the two proximal leaflets begin to mix. This is the
hemi-fused state. We envision this state to be a rather
dynamic state, in which the lipids do not adopt a well-
defined orientation. The fusion (and perhaps the TM)
peptides may act like lipid ‘‘mixers’’ at this stage (Fig.
6B). (7) We propose that a direct interaction between the
fusion and TM peptides is required to open the fusion pore.
This has already been suggested based on the observation
of the capped crystal structure of the ectodomain at pH 5
[7] and is reinforced by the fact that independent mutations
in the fusion and TM peptides lead to the same hemifusion
phenotype [26,43]. The interaction between the TM domain
and the fusion peptide probably requires the conserved
glycine ridge on the upper face of the N-terminal arm of
the fusion peptide structure. Helix–helix interactions in
membranes are often mediated by glycine-rich helical
surfaces, as shown, for example, in the structure of the
glycophorin A dimer [44]. To actually open the fusion pore,
the fusion peptides whose N-terminal arms are too short to
span the membrane are hypothesized to slide down the TM
domains using them as guiding rails and thereby open their
own angled (boomerang) conformation into a more extend-
ed membrane spanning helix. The fusion peptides and TM
domains of several, perhaps even a large number of HA
Fig. 6. Boomerang model of influenza hemagglutinin-mediated membrane fusion. (A) The pH-induced conformational change in the ectodomain thrusts the
boomerang-shaped fusion peptides towards the target membrane where it inserts. (B) The ectodomains tilt relative to the plane of the membranes. The
boomerangs retrieve the target membrane and bring it to close juxtaposition with the viral membrane such that lipid exchange (hemi-fusion) can occur. (C) The
fusion peptides and transmembrane domains are thought to interact by virtue of the glycine-edge of the fusion peptide in order to open the initial fusion pore.
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(Fig. 6C).7. Some questions for the future
As mentioned, many aspects of the spring-loaded boo-
merang model are still hypothetical and need to be exper-
imentally verified before this model can be accepted in full.
Several important questions need to be answered: Are the
coiled coils N-terminally extended before the C-terminal
helices are packed antiparallel against the core helices? And
related, do the fusion peptides reach the target membrane
before the ectodomains tilt? When do HA trimers assemble
to form a distinct fusion site? What are the molecular
interactions and driving forces that lead to this assembly?
How is a symmetric molecule such as HA biased to tilt in aspecific direction? (An appealing possibility is that breaking
the symmetry of individual molecules could be facilitated
by imposing a new supra-molecular symmetry encountered
in the oligomeric fusion complex. This would imply that the
fusion complex has to form before the molecules tilt.) What
intermediate lipid configurations are adopted and what is the
geometry of the ‘‘hemifusion’’ intermediate? How do fusion
peptides interact with TM domains? What are the molecular
contacts, stoichiometries and interaction energies? What is
the structural correlate of the pore ‘‘flickering’’ that has been
observed in electrophysiological experiments? What is the
irreversible switch that finally opens the fusion pore? Why
is this initial fusion pore energetically unstable? Why and
how does the initial pore dilate and eventually form an
unrestricted single membrane around the viral and cellular
compartment? Answering these and other challenging ques-
tions will likely guide future research that is directed at
L.K. Tamm / Biochimica et Biophysica Acta 1614 (2003) 14–23 23uncovering the mechanics of the molecular machine that
fuses viral and cellular membranes.Acknowledgements
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